NOV 19, 2015 09:20 AM PST

Finally Catching Small Cell Lung Cancer Before Metastasis

WRITTEN BY: Kara Marker
Small cell lung cancer (SCLC) has a long history of evading both the immune system and scientists trying to study how it does so, and patients with SCLC rarely get diagnosed before the cancer has metastasized. Scientists from the Medical University of Vienna in Austria, where increasing amounts of people are dying from lung cancer, were finally able to obtain enough cancer cell material to determine how these tumors remain so pervasive. Dr. Gerhard Hamilton, leader of the study, and his team published their findings this week in OncoImmunology.

Difficulty in SCLC detection most often leads to poor prognoses and harsh treatments. Irradiation and cytotoxic chemotherapy are the only options, since surgery is ineffective. Cytotoxic chemotherapy drugs are injected into the bloodstream with the goal of impeding cancer cell ability to divide and grow, leading to their destruction (Northern Health and Social Care Trust). Normal human cells also need to divide and grow to survive though, so this therapy often has unfortunate side effects for cancer patients. In both Austria and America where lung cancer kills thousands of people every year, about 15% of lung cancers are diagnosed as SCLC, most often in people who have a history of smoking (Cancer.org). 

Scientists studying SCLC constantly had trouble obtaining "enough cell material available for biomolecular analysis," a major roadblock in figuring out how tumors would shrink initially after chemotherapy and then return resistant to the harshest treatments. In developing a new method for obtaining and cultivating samples for study, Hamilton and his team have made major advances in the battle against SCLC.

Their established method for "cultivating the circulating tumor cells (CTCs)" made it possible for the team to determine the mechanisms behind the cancer cells' immune system evasion.

First, CTCs manipulate the local microenvironment to stimulate monocyte differentiation into macrophages. At first this seems counterintuitive since macrophages function to phagocytose abnormal cells like tumor cells. However, CTCs also alter macrophage cytokine expression to the point where the lymphocytes not only fail to attack and kill the cancerous cells, but also change the local conditions themselves to enhance CTCs' ability to spread.

In the words of the scientific team, "CTCs are competent to specifically manipulate tumor-associated macrophages to increase invasiveness, angiogenesis, immunosuppression, and possibly lipid catabolism."

Now that the team from Vienna understands monumentally more about SCLC evasion of the immune system, the next step is to determine how cancer recurrence is accompanied by resistance to treatment. 

Watch the following video to learn more about how SCLC is diagnosed and how doctors create treatment plans.

Source: University Department of Surgery at the Medical University of Vienna



 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 19, 2018
Cell & Molecular Biology
NOV 19, 2018
How Mitochondria can Help the Cell Fight Pathogens
Some pathogens can get around out bodies' natural defense mechanisms. So our body developed a Plan B....
DEC 04, 2018
Immunology
DEC 04, 2018
Shared Bacteria After Birth
A study reveals the benefits of natural birth over cesarean birth in regards to immune development...
DEC 26, 2018
Immunology
DEC 26, 2018
When the Immune System Makes a Mistake: Autoimmunity
A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells....
JAN 15, 2019
Immunology
JAN 15, 2019
Unconventional T Cells
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2 percent of the Western population. Scientists report that rare populations of unconvention...
JAN 30, 2019
Immunology
JAN 30, 2019
T Cell Stimulation for Zika Vaccine Design
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus...
MAR 19, 2019
Health & Medicine
MAR 19, 2019
Can a Low-Carb Diet Treat Osteoarthritis?
A pilot study suggests it might. Researchers at the University of Alabama, Birmingham, found that a low-carbohydrate diet was able to reduce pain intensity...
Loading Comments...